
Synergy Shield Coronary Stent 2.25 X 8 | REF H7493966608220
Boston Scientific Synergy Shield Coronary Stent, 2.25 mm x 8 mm, REF H7493966608220. Single-unit B2B catalog listing for hospital and cath lab procurement.

The Terumo Ultimaster Nagomi Coronary Stent (REF DE-RS2209ASM) is a sirolimus-eluting coronary stent system pre-mounted on a rapid-exchange delivery catheter. With a labelled size of 2.25 mm diameter × 9 mm length, this device is intended for use by trained interventional cardiologists in cardiac catheterisation laboratories. The Ultimaster Nagomi platform features a thin-strut cobalt-chromium scaffold combined with an abluminal bioresorbable polymer coating designed to release sirolimus over a defined elution period.
Key Features
Thin-strut cobalt-chromium stent platform engineered for deliverability and conformability.
Abluminal bioresorbable PDLLA-PCL polymer coating for directional drug release.
Sirolimus as the active pharmaceutical agent.
Rapid-exchange (monorail) delivery catheter for single-operator handling.
Pre-mounted, sterile, single-use configuration.
Distal small-vessel size 2.25 mm × 9 mm length suitable for narrow coronary anatomy.
Clinical Applications
Indicated for use in percutaneous coronary intervention (PCI) procedures as labelled by the manufacturer.
Designed to support treatment of de novo coronary artery lesions in vessels of compatible reference diameter.
Refer to the official Instructions for Use (IFU) for complete indications, contraindications, warnings, precautions, and approved patient population.
Product Information
Brand: Terumo
Product line: Ultimaster Nagomi
Category: Coronary Stents
REF / UPN: DE-RS2209ASM
Stent diameter: 2.25 mm
Stent length: 9 mm
Drug: Sirolimus
Polymer: Bioresorbable abluminal coating
Scaffold material: Cobalt-chromium alloy
Delivery system: Rapid-exchange catheter
Guide wire compatibility: Not specified in the located sources
Guiding catheter compatibility: Not specified in the located sources
Sterilisation: Sterile, single use
Storage and shelf life: Refer to product labelling
Regulatory status: Refer to local labelling and the official IFU for the destination market.
Practical answers for procurement teams reviewing this product page.
Include the exact product family, brand preference, REF/UPN code when available, required quantity, destination country, expected delivery timing and documentation expectations.
Yes. If alternatives are acceptable, mention equivalent brands, compatible models, size ranges and any non-negotiable requirements.
Related products are connected through structured catalog data such as brand, category, product family and country assignment.
No. This page supports sourcing and RFQ organization. Buyers must verify regulatory status, clinical suitability and procurement compliance independently.
Specific codes reduce ambiguity and help supplier teams identify product availability, packaging details and documentation faster.
Yes. The workflow is designed for hospitals, clinics, distributors, wholesalers, importers and procurement departments.
Yes. Products can be connected to multiple countries in the admin panel, and buyers can specify destination details in the RFQ form.
The request is stored with contact and procurement details so the sourcing conversation can be reviewed and followed up clearly.